| __timestamp | AstraZeneca PLC | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 15411924 |
| Thursday, January 1, 2015 | 5997000000 | 22593274 |
| Friday, January 1, 2016 | 5890000000 | 33173050 |
| Sunday, January 1, 2017 | 5757000000 | 62224159 |
| Monday, January 1, 2018 | 5932000000 | 95607434 |
| Tuesday, January 1, 2019 | 5958000000 | 221269028 |
| Wednesday, January 1, 2020 | 5991000000 | 400745069 |
| Friday, January 1, 2021 | 9736000000 | 580520000 |
| Saturday, January 1, 2022 | 9762000000 | 663366000 |
| Sunday, January 1, 2023 | 10935000000 | 755113687 |
| Monday, January 1, 2024 | 13583000000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, AstraZeneca PLC and argenx SE have demonstrated contrasting strategies in their R&D investments. AstraZeneca, a global leader, has consistently allocated substantial resources, with a notable 96% increase in R&D expenses from 2014 to 2023. In 2023 alone, AstraZeneca's R&D spending reached a peak, reflecting its commitment to pioneering new treatments.
Conversely, argenx SE, a rising star in the biotech sector, has shown a remarkable growth trajectory, with R&D expenses skyrocketing by over 4,800% during the same period. This surge underscores argenx's aggressive push to innovate and expand its therapeutic portfolio. As these two companies continue to invest in R&D, their strategies highlight the diverse approaches within the pharmaceutical industry to drive future growth and breakthroughs.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or argenx SE: Who Invests More in Innovation?
argenx SE or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
argenx SE or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: argenx SE vs Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for argenx SE and Protagonist Therapeutics, Inc.
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.